|Other Names||TATA box-binding protein-associated factor RNA polymerase I subunit D, RNA polymerase I-specific TBP-associated factor 41 kDa, TAFI41, TATA box-binding protein-associated factor 1D, TBP-associated factor 1D, Transcription initiation factor SL1/TIF-IB subunit D, TAF1D, JOSD3|
|Format||Synthetic peptide was lyophilized with 100% acetonitrile and is supplied as a powder. Reconstitute with 0.1 ml DI water for a final concentration of 1 mg/ml.|
|Storage||Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C.|
|Precautions||This product is for research use only. Not for use in diagnostic or therapeutic procedures.|
|Function||Component of the transcription factor SL1/TIF-IB complex, which is involved in the assembly of the PIC (preinitiation complex) during RNA polymerase I-dependent transcription. The rate of PIC formation probably is primarily dependent on the rate of association of SL1/TIF-IB with the rDNA promoter. SL1/TIF-IB is involved in stabilization of nucleolar transcription factor 1/UBTF on rDNA. Formation of SL1/TIF-IB excludes the association of TBP with TFIID subunits.|
|Cellular Location||Nucleus EMBL; AK027016; BAB15628.1; -; mRNA EMBL; CR457369; CAG33650.1; -; mRNA EMBL; BC001972; AAH01972.1; -; mRNA CCDS; CCDS8293.1; - RefSeq; NP_077021.1; NM_024116.3 UniGene; Hs.355750; - ProteinModelPortal; Q9H5J8; - SMR; Q9H5J8; - BioGrid; 122548; 54 IntAct; Q9H5J8; 40 MINT; MINT-8247602; - STRING; 9606.ENSP00000314971; - iPTMnet; Q9H5J8; - PhosphoSitePlus; Q9H5J8; - BioMuta; TAF1D; - DMDM; 74733586; - EPD; Q9H5J8; - MaxQB; Q9H5J8; - PaxDb; Q9H5J8; - PeptideAtlas; Q9H5J8; - PRIDE; Q9H5J8; - DNASU; 79101; - Ensembl; ENST00000323981; ENSP00000314971; ENSG00000166012 Ensembl; ENST00000448108; ENSP00000410409; ENSG00000166012 Ensembl; ENST00000526015; ENSP00000435087; ENSG00000166012 GeneID; 79101; - KEGG; hsa:79101; - UCSC; uc001ped.5; human CTD; 79101; - DisGeNET; 79101; - GeneCards; TAF1D; - HGNC; HGNC:28759; TAF1D HPA; HPA055935; - HPA; HPA060385; - MIM; 612823; gene neXtProt; NX_Q9H5J8; - OpenTargets; ENSG00000166012; - PharmGKB; PA164726421; - eggNOG; ENOG410IZI3; Eukaryota eggNOG; ENOG41124VA; LUCA GeneTree; ENSGT00390000009061; - HOGENOM; HOG000154498; - HOVERGEN; HBG096071; - InParanoid; Q9H5J8; - KO; K15215; - OMA; NEDFDSR; - OrthoDB; EOG091G0D0N; - PhylomeDB; Q9H5J8; - TreeFam; TF335756; - BioCyc; ZFISH:ENSG00000166012-MONOMER; - Reactome; R-HSA-427359; SIRT1 negatively regulates rRNA Expression Reactome; R-HSA-427413; NoRC negatively regulates rRNA expression Reactome; R-HSA-5250924; B-WICH complex positively regulates rRNA expression Reactome; R-HSA-73762; RNA Polymerase I Transcription Initiation Reactome; R-HSA-73772; RNA Polymerase I Promoter Escape Reactome; R-HSA-73777; RNA Polymerase I Chain Elongation Reactome; R-HSA-73863; RNA Polymerase I Transcription Termination ChiTaRS; TAF1D; human GenomeRNAi; 79101; - PRO; PR:Q9H5J8; - Proteomes; UP000005640; Chromosome 11 Bgee; ENSG00000166012; - CleanEx; HS_TAF1D; - ExpressionAtlas; Q9H5J8; baseline and differential Genevisible; Q9H5J8; HS GO; GO:0005815; C:microtubule organizing center; IDA:HPA GO; GO:0005654; C:nucleoplasm; IDA:HPA GO; GO:0005668; C:RNA polymerase transcription factor SL1 complex; IEA:InterPro GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW GO; GO:0045815; P:positive regulation of gene expression, epigenetic; TAS:Reactome GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW GO; GO:0006363; P:termination of RNA polymerase I transcription; TAS:Reactome GO; GO:0006362; P:transcription elongation from RNA polymerase I promoter; TAS:Reactome GO; GO:0006361; P:transcription initiation from RNA polymerase I promoter; TAS:Reactome InterPro; IPR027976; TAF1D PANTHER; PTHR14562; PTHR14562; 1 Pfam; PF15333; TAF1D; 1 1: Evidence at protein level; Complete proteome; DNA-binding; Nucleus; Phosphoprotein; Reference proteome; Transcription; Transcription regulation CHAIN 1 278 TATA box-binding protein-associated factor RNA polymerase I subunit D /FTId=PRO_0000250717 MOD_RES 23 23 Phosphoserine MOD_RES 138 138 Phosphoserine MOD_RES 234 234 Phosphoserine CONFLICT 14 14 S -> T (in Ref. 3; CAG33650) CONFLICT 97 97 R -> G (in Ref. 3; CAG33650) CONFLICT 278 278 M -> I (in Ref. 3; CAG33650) SEQUENCE 278 AA; 32058 MW; 4BA37C73BB387446 CRC64; MDKSGIDSLD HVTSDAVELA NRSDNSSDSS LFKTQCIPYS PKGEKRNPIR KFVRTPESVH ASDSSSDSSF EPIPLTIKAI FERFKNRKKR YKKKKKRRYQ PTGRPRGRPE GRRNPIYSLI DKKKQFRSRG SGFPFLESEN EKNAPWRKIL TFEQAVARGF FNYIEKLKYE HHLKESLKQM NVGEDLENED FDSRRYKFLD DDGSISPIEE STAEDEDATH LEDNECDIKL AGDSFIVSSE FPVRLSVYLE EEDITEEAAL SKKRATKAKN TGQRGLKM|
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abgent to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
firstname.lastname@example.org, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
TAF1D is a member of the SL1 complex, which includes TBP(MIM 600075) and TAF1A (MIM 604903), TAF1B (MIM 604904), and TAF1C(MIM 604905), and plays a role in RNA polymerase I transcription(Wang et al., 2004 [PubMed 15520167]; Gorski et al., 2007 [PubMed17318177]).
Gorski, J.J., et al. EMBO J. 26(6):1560-1568(2007)Wang, L., et al. Cancer Res. 64(21):7673-7677(2004)
If you have used an Abgent product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at email@example.com.